Cardiovascular diseases

  • Health outcome assessment in chronic thromboembolic pulmonary arterial hypertension patients treated with riociguat: 2-year results from the CHEST-2 long-term extension study
    Bonner N, Brockmann B, Busse D, de la Orden M, Gater A, Mathai SC, Minai OA, Teal S.
    Poster presented at the PHA Conference, Dallas, Texas, USA, June 17–19 2016
  • Health outcome assessment in pulmonary arterial hypertension patients treated with riociguat: 2-year results from the PATENT-2 long-term extension study
    Bonner N, Brockmann B, Busse D, de la Orden M, Gater A, Mathai SC, Minai OA, Teal S.
    Poster presented at the PHA Conference, Dallas, Texas, USA, June 17–19 2016
  • Development and content validation of a patient-reported outcome measure to evaluate statin intolerance in the real world
    Jacobson T, Edelman S, Davidson M, Galipeau N, Shields A, Mallya UG, Koren A.
    Poster presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 21st Annual International Meeting, Washington DC, USA, 21-25 May 2016
  • Psychometric evaluation of a new patient-reported outcome (PRO) symptom diary for varicose veins: VVSymQ® instrument
    Wright DD, Paty J, Turner-Bowker DM, Bradbury A.
    Patient. Epub ahead of print Mar 25. 2016. DOI 10.1007/s40271-015-0159-3
  • Psychometric validation of the Heart Failure Caregiver Questionnaire (HF-CQ v5.0)
    Strömberg A, Bonner N, Grant L, Bennett B, Chung ML, Jaarsma T, Luttik ML, Lewis E, Calado F, Deschaseaux C.
    Poster session presented at the EuroHeartCare Conference, Dubrovnik, Croatia, 14-15 June 2015
  • Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria
    Bonner N, Kimura A, Panter C, Sinert R, Moellman JJ, Bernstein JA.
    Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 20th Annual International Congress, Philadelphia, PA, USA, 16-20 May 2015
  • Expert review on development of patient measure for statin intolerance
    Foody JM, Sauris A, Edelman SV, Davidson M, Galipeau N, Shields AL, Jacobson TA.
    Poster session presented at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions, Baltimore, USA, 29 April-1 May 2015
  • Psychometric validation of the caregiver burden questionnaire for heart failure (CBQ-HF v4.0)
    Stromberg A, Bonner N, Grant L, Bennett B, Chung M, Jaarsma T, Calado F, Deschaseaux C.
    Eur J Cardiovasc Nurs 2015; 14: S75-S76.
  • Development and Validation of the AFSymp™: An Atrial Fibrillation-Specific Measure of Patient-Reported Symptoms
    Arbuckle R, Abetz L, Medin J, Halling K, Kulich K, Edvardsson K, Coyne KS.
    Patient 2014;7;319-327
  • Patient- and clinician-reported satisfaction with pharmacological stress agents for single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI)
    Hudgens S, Breeze J, Spalding J.
    J Med Econ 2013;16(6):828-34
  • Real-world resource utilization and costs following hospitalization of patients with heart failure and preserved ejection fraction in five regions of China
    Li X, Crawford B, Wang D, Deschaseaux C, Liu L.
    Poster presented at: Great Wall International Congress of Cardiology Beijing, China, 10-13 October 2013
  • Comparative efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: A network meta-analysis with the adjustment for the possible bias from open label studies
    Morimoto T, Crawford B, Wada K, Ueda S.
    Poster presented at European Society of Cardiology, Amsterdam, Netherlands, 30 August – 4 September 2013
  • Real-World Characterization of Hypertension Patients in Japan: A 1-Year Overview
    Crawford B, Ong SH, Falvey H.
    Asian J Pharmaceutical and Clinical Research 2013; 6 (suppl 4): 93-96
  • The post-stroke checklist: A tool for standardizing long-term patient follow up
    Ward A, Chen C, Norrving B, Gillard P, Walker M, Blackburn S, Brainin M, Philp I. on behalf of the Global Stroke Community Advisory Board.
    Poster presented at the 8th Annual World Stroke Congress, Brasilia, Brazil, 10-13 October 2012
  • Real-world characterization of hypertension patients in Japan: a 1-year overview
    Crawford B, Ong SH, Falvey H.
    Oral presentation at the International Society for Pharmacoeconomics and Outcomes Research, 5th Asia-Pacific Conference, Taipei, Taiwan, 2–4 September 2012
  • A novel conceptual model of caregiver burden in chronic heart failure: a qualitative study
    Blackburn S, Humphrey L, Maguire L, Deschaseaux C, Strömberg A.
    Value in Health 2012;15:A378
  • The Caregiver Burden Questionnaire for Chronic Heart Failure (CBQ-CHF): development and validation
    Blackburn S, Strömberg A, Humphrey L, Maguire L, Deschaseaux C.
    J Card Fail 2012;18:S83
  • Real world patient profile of patients with Reduced Ejection Fraction Heart Failure (HF-REF) in 5 regions of China
    Li XY, Crawford B, Liao YH.
    Value in Health 2012;15:A129
  • Development of a patient-reported outcome measure and a clinician-reported outcome measure to assess satisfaction and preference with pharmacological stress agents for single photon emission computed tomography myocardial perfusion imaging
    Hudgens S, Kothari S, Spalding J.
    Qual Life Res 2012;20:30
  • Real-World Costs of Reduced Ejection Fraction Heart Failure (HF-REF) from 5 regions of China
    Li XY, Liao YH, Crawford B, Tanaka E, Wang D, Ariely R, Zheng J, McDonald J.
    Poster presented at the Asia-Pacific Congress of Heart Failure, 3–5 February 2012, Chiang Mai, Thailand
  • Development of a post stroke checklist to standardize long-term stroke care
    Philp I, Brainin M, Walker M, Ward A, Gillard P, Shields AL, Norrving B and the Global Stroke Community Advisory Board.
    Journal of Stroke and Cerebrovascular Diseases 2012;12:S1052-3057
  • Evaluation of the measurement properties of the antihypertensive adherence survey
    Hudgens S.
    Value in Health 2011;14:A382
  • Validation of a Patient-Reported Outcome (PRO) measure and a Clinician-Reported Outcome (CRO) Measure to assess satisfaction and preference with pharmacological stress agents for Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
    Hudgens S, Kothari S.
    Value in Health 2011;14:A255
  • Understanding of stroke and coronary heart disease in the UK: an exploratory study
    Ayers BN, Myers LB.
    Psychol Health Med 2010;15:474
  • Cost-effectiveness of valsartan in Japan: results from the jikei heart study
    Shimizu M, Crawford B, Ikewaki K, Taniguchi I, Kamae I, Dahlof B, Drost P, Mochizuki S.
    Value in Health 2009;12:A151
  • Development and content validity testing of a patient-reported treatment acceptance measure for use in patients receiving treatment via subcutaneous injection
    Tatlock S, Grant L, Spertus J, Khan I, Arbuckle R, Manvelian G, Sanchez R
    Value in Health 2015;18;8:1000-1007